Founded

Address

Bay City Capital LLC
750 Battery Street
Suite 400
San Francisco, CA 94111
United States

Open map


Recent investment activity

KANDO id: 2637

Corporate information

Registration country

Funding rounds

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 51 - 64 of 64
Profile Country Date Funding
VIA Pharmaceuticals Inc Drug development company targeting vascular inflammation. N/A
Vivaldi Biosciences Inc Developing novel genetically modified vaccines to protect against common seasonal influenza and emergent pandemic influenza. N/A
VNUS Medical Technologies Inc VNUS markets a minimally invasive medical device to treat venous disease, including venous reflux and vein valve incompetence. N/A
Altheos Inc A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. N/A
Calypso Medical Technologies Inc A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. Series E
Calypso Medical Technologies Inc A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. Series C
Ingenuity Systems Inc N/A
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. N/A
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. N/A
Pharmanex LLC Create safe and efficient dietary supplements by applying the disciplines of Western science to natural products. N/A
Sembiosys Genetics Inc Developer of high value proteins and oil body based products for personal care, nutrition and pharmaceutical industries. N/A
Symyx Technologies Develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications. N/A
ZymoGenetics Inc Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. N/A
Trade sale
Profile Country Funding
Ion Torrent Systems Inc ION Torrent Systems pioneered an entirely new approach to sequencing that enables a direct connection between chemical and digital information. N/A Initial investment Exited Trade sale

Current team

Past employees

Selected Products / Customers

Financials